Top Markets
#1 MowCat MowCat +368.91%
#2 龙虾 (Lobster) 龙虾 (Lobster) +67.78%
#3 SODAX SODAX +51.82%
#4 Cortex Cortex +32.58%
#5 MarsCoin MarsCoin +23.54%
#6 DexNet DexNet +23.19%
#7 OpenEden OpenEden +20.03%
#8 Magma Finance Magma Finance +17.47%
#9 wojak wojak +16.12%
#10 Akedo Akedo +15.73%
Coin of the day
MowCat MowCat
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Biotest AG Biotest AG

Biotest AG

BIO
Hisse Senetlerindeki Sıralama #7311
Biotest AG is a German biopharmaceutical company focused on the global... Biotest AG is a German biopharmaceutical company focused on the global development, manufacturing, and commercialization of biological medications. The firm organizes its activities into the Therapy, Plasma & Services, and Other segments. Its product portfolio addresses critical needs in hematology, clinical immunology, and intensive care medicine. Among its offerings are treatments for hemophilia A (such as Haemoctin and Vihuma) and hemophilia B (like Haemonine), covering both acute care and prevention. Biotest also provides therapies for various viral infections, including cytomegalovirus (Cytotect CP), hepatitis B (Fovepta, Hepatect, Zutectra), and varicella zoster (Varitect). Additionally, its products, such as Intratect and IgG Next Generation, are utilized for primary and secondary immune deficiencies, autoimmune disorders, and certain neurological conditions. The company further supplies solutions to manage circulating blood volume (Albiomin, Biseko), address clotting factor deficiencies (Cofact, Fibrinogen), and combat serious infections like community-acquired pneumonia and COVID-19 (Trimodulin), as well as general bacterial infections (Pentaglobin). Established in 1946 as Biotest Serum-Institut GmbH, the company adopted its current name, Biotest Aktiengesellschaft, in 1986. Headquartered in Dreieich, Germany, Biotest Aktiengesellschaft has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
Hisse Fiyatı
$47.45
Son senkronizasyon: 2026-05-13
Piyasa Değeri
$1.63B
Değişim (1 gün)
2.04%
Değişim (1 yıl)
3.15%
Ülke
DE
Ticaret Biotest AG (BIO)

Kategori

Healthcare
Biotest AG (BIO) için gelir
Aug 2026 itibarıyla gelir TTM: 0
Biotest AG şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Biotest AG için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH